Scientists Playing God are Building Human DNA From the Ground Up
Biological science has made such astonishing leaps in the last few decades, such as precise gene editing, that scientists are now tackling the next logical — yet inherently controversial — step: fabricating human DNA from the ground up.
Details are a bit vague, but a team of scientists in the United Kingdom have embarked on a new project to construct what they describe in a statement as the "first synthetic human chromosome."
The scientists hope that the five-year Synthetic Human Genome project will result in better understanding of the essential building blocks that make human life possible and find clues to cure diseases and debilitating genetic conditions — so it's not like they are trying to make life from nothing like God, a well-used plot line in lots of science fiction movies.
"The ability to synthesize large genomes, including genomes for human cells, may transform our understanding of genome biology and profoundly alter the horizons of biotechnology and medicine," said Jason Chin, a biology professor at Oxford University and one of the project leads.
The medical non-profit, Wellcome Trust, is kicking in an initial $13.7 million for the project, which builds on the successfully completed project to map the entire human genome, which Wellcome also funded, according to the BBC.
Making synthetic genomes isn't an entirely novel endeavor. Back in 2010, scientists managed to make from scratch the whole genome of a simple bacterium, and then plugged its genetic material inside an empty cell of another bacterium, making something entirely new that they cleverly dubbed Synthia. Scientists have also synthesized viral and yeast cells in other research.
But a human genome is an entirely different proposition. For one thing, it involves a vastly more complex organism than some bacteria. And two, ethical concerns abound. Any whiff of messing around with human DNA has the stink of designer babies and eugenics.
Because of these concerns, the project has a social research component.
"Over the next five years, the team will undertake a transdisciplinary and transcultural investigation into the socio-ethical, economic, and policy implications of synthesising human genomes," the statement on the research reads.
That sentence does feel a bit vague — so we'll be closely watching this project to see how it plays out in more concrete terms.
At the end of the five years, the project leaders hope they'll have a finished human chromosome. That will be a huge step for biological progress — but there will no doubt be many ethical questions to unpack. Starting with: what's the meaning of life, if we can make it ourselves?
More on DNA: You Can Now Buy a Sample of Ozzy Osbourne's DNA in Twelve Easy Payments
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Scientists break out infrared tech to solve issue holding back next-gen solar panels: 'This makes the technology promising not just in the lab'
In a major leap for clean energy, scientists have figured out how to make solar panels that are lighter, more efficient, and — for the first time — durable enough for everyday use. A research team led by the Swiss Federal Institute of Technology in Lausanne, Switzerland, has developed a new method for making perovskite solar cells more stable in real-world conditions. The results, published in Joule, are exciting for solar fans everywhere. Perovskites have long been considered the future of solar. Unlike traditional silicon panels, they are ultra-light and low-cost and can be printed onto flexible surfaces. Think solar-powered windows, walls, or even wearable electronics. But until now, they've had one big flaw: They don't hold up well to sunlight and heat over time. According to this study in collaboration with the Polytechnic University of Milan, that might be about to change. The researchers found that by adding a molecule called TEMPO to the perovskite layer and hitting it with a quick infrared pulse — just half a second long — they could repair tiny defects in the material. This new process gives the panel efficiency of over 20% and maintains it for months under typical working conditions. "The proposed method is fast, solvent-free, and compatible with roll-to-roll processing, similar to that used in the printing industry. This makes the technology promising not just in the lab, but also for future industrial-scale production," explained Rafael Ferragut, researcher, teacher, and co-author of the study. For consumers, this could mean a new generation of solar products that are cheaper, lighter, and more versatile. These panels could help homeowners and cities break free from high, unpredictable utility bills by giving them more control over when and where they generate power. It also means reducing planet-warming pollution that harms public health and the environment. While the tech may still be in development, this breakthrough brings us one step closer to a future where clean energy is embedded into everyday life — literally. Installing solar panels is the ultimate home energy hack because it can bring your cost of energy down to or close to $0. EnergySage provides a free service that makes it easy to compare quotes from vetted local installers and save up to $10,000 on solar installations. For those not ready to buy, leasing is a great option. Palmetto's LightReach program locks in low energy rates for homeowners who want to switch to solar without paying high upfront costs. Community solar programs are another alternative for people who can't install panels but would like to benefit from lower energy costs and a more stable power supply. What is the biggest factor you consider when planning a vacation? Cost Distance from home Whether it's family-friendly Sightseeing and entertainment Click your choice to see results and speak your mind. Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the planet.
Yahoo
an hour ago
- Yahoo
Controversial project could create human DNA from scratch
A controversial project that aims to create the building blocks of human life has started. It was previously thought creating human DNA could lead to designer babies or unforeseen complications and changes for future generations. However, in a world first, medical charity the Wellcome Trust, has given an initial £10m to start the project. Scientists say it has the potential to transform the understanding of human health, open opportunities to develop treatments for incurable diseases and develop climate-resistant crops. 'Our DNA determines who we are and how our bodies work,' said Michael Dunn, director of discovery research at Wellcome. 'Through creating the necessary tools and methods to synthesise a human genome, we will answer questions about our health and disease that we cannot even anticipate yet, in turn transforming our understanding of life and wellbeing.' In the next five to ten years scientists aim to build a full synthetic human chromosome. Every cell in the human body contains DNA, which is a molecule that carries genetic information that physically makes people who they are. The new Synthetic Human Genome Project will potentially allow researchers not just to be able to read DNA but create parts of it. Scientists will first aim to create larger blocks of human DNA to try to create a synthetically constructed a human chromosome – which contains genes that govern our development, repair and maintenance. These chromosomes would then be studied to find out how genes and DNA regulate our bodies. The project is led by Professor Jason Chin from the Generative Biology Institute at Ellison Institute of Technology and the University of Oxford, in collaboration with team of researchers from Cambridge, Kent, Manchester, Oxford and Imperial College London. 'The ability to synthesize large genomes, including genomes for human cells, may transform our understanding of genome biology and profoundly alter the horizons of biotechnology and medicine,' said Professor Chin. The project will be confined to test tubes and petri dishes, with no attempt to create synthetic life. But critics fear the research opens the way for researchers to create enhanced or modified humans. Professor Bill Earnshaw, a genetic scientist at Edinburgh University who designed a method for creating artificial human chromosomes fears this research could open the opportunity to attempt to create biological weapons, enhanced humans or even creatures that have human DNA. "The genie is out of the bottle," he told BBC News. "We could have a set of restrictions now, but if an organisation who has access to appropriate machinery decided to start synthesising anything, I don't think we could stop them." There will also be a dedicated social science project running alongside the researchers led by Professor Joy Zhang, a sociologist, at the University of Kent. "We want to get the views of experts, social scientists and especially the public about how they relate to the technology and how it can be beneficial to them and importantly what questions and concerns they have," she said.
Medscape
an hour ago
- Medscape
Plant Extracts Show Promise in Hand Osteoarthritis Relief
TOPLINE: In patients with symptomatic hand osteoarthritis (OA) who took two tablets daily containing a combination of patented plant extracts of Curcuma longa and Boswellia serrata, a significant reduction in pain was observed compared with that in those who took placebo over 3 months, with a favourable safety profile. METHODOLOGY: Researchers conducted a double-blind, randomised controlled trial across 11 centres in Belgium (2022-2024) to evaluate the efficacy and safety of the combination of plant extracts in hand OA. They included 162 adults with symptomatic hand OA (mean age, 63.1 years; 76.5% women) who reported hand pain on ≥ 50% of days in the prior month and ≥ 48 hours before baseline, with pain ranging from 40 to 80 mm on a 100-mm visual analog scale (VAS) in at least one hand over the last 24 hours. The patients were randomly assigned to receive two identical looking tablets of either the combination of plant extracts (n = 83) or placebo (n = 79) daily for 3 months. The primary outcome was the mean change in finger pain on both hands during the past 24 hours on the VAS over 3 months. Several secondary outcomes evaluated at months 1 and 3 included pain on the VAS, number of painful and swollen joints, patient global assessment, and quality of life. Safety outcomes were assessed throughout the study. TAKEAWAY: At month 3, patients who received the plant extracts had a greater mean VAS pain reduction of 24.7 mm compared with 16.2 mm in those who received placebo (difference, -8.5 mm; P = .03); similar benefit was observed at month 1 (difference, -7.0 mm; P = .04). Patients receiving the plant extracts vs placebo showed significant improvements in the patient global assessment (difference, -9.6 mm; P = .01) and quality of life score (P = .01) at month 3. Mean global compliance was more than 90% in both groups, with no significant difference. The number of adverse effects did not differ significantly between the two groups, and most of them were unrelated to the use of plant extracts. IN PRACTICE: "The investigational product used in the study is an option for healthcare providers and researchers working on novel pain relief products," the authors wrote. SOURCE: This study was led by Yves Henrotin, Princess Paola Hospital and University of Liège, Liège, Belgium. It was published online on June 17, 2025, in Osteoarthritis and Cartilage. LIMITATIONS: The authors excluded the evaluation of short-term pain to confirm the rapid action of the combination of plant extracts. Imaging outcomes including x-ray or ultrasound were missing, which prevented the assessment of inflammation or bone erosion. Multiple secondary endpoints may have affected the statistical interpretation, with increased odds of obtaining the significant results. DISCLOSURES: This study received funding from Tilman SA. Two authors reported receiving speaker fees from the funding agency. REFERENCES: Henrotin Y, de Schrijver F, De Vlam K, et al. Effect of a combination of C. longa and B. serrata extracts on hand osteoarthritis. Results of a double-blind, randomised, placebo-controlled, multicenter trial. Osteoarthr Cartil. Published online June 17, 2025. doi:10.1016/ This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
